Human medicines European public assessment report (EPAR): Vitrakvi, larotrectinib, Abdominal Neoplasms, Date of authorisation: 19/09/2019, Revision: 10, Status: Authorised
Human medicines European public assessment report (EPAR): Vitrakvi, larotrectinib, Abdominal Neoplasms, Date of authorisation: 19/09/2019, Revision: 10, Status: Authorised
